SCHEMBL18398367

SCHEMBL18398367

CCc1cn(C)c(=O)cc1N(C)c1cc2c(ncn2C)c(NC(=O)C2CC2)n1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 7/20 0.47
▸ JAK2 O60674 6/20 0.47
▸ JAK1 P23458 5/20 0.47
▸ JAK3 P52333 5/20 0.47
▸ PIK3C3 Q8NEB9 1/20 0.38
▸ MAP4K1 Q92918 1/20 0.34
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ GSK3B P49841 4/20 0.32
▸ DYRK1A Q13627 4/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ WNT1 P04628 3/20 0.31
▸ ABL1 P00519 2/20 0.31
▸ MAPT P10636 1/20 0.31
▸ MTNR1A P48039 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409345 0.83 JAK2 (0.50) TYK2JAK2JAK1JAK3MEN1
SCHEMBL18398368 0.82 JAK2 (0.45) TYK2JAK2JAK1JAK3PIK3C3
SCHEMBL18398230 0.81 TYK2 (0.56) TYK2JAK2JAK1JAK3KDM4E
SCHEMBL18398479 0.81 JAK2 (0.52) TYK2JAK2JAK1JAK3MAP4K1
SCHEMBL18409158 0.81 TYK2 (0.58) TYK2JAK2JAK1JAK3GSK3B
SCHEMBL18409324 0.80 JAK2 (0.59) TYK2JAK2JAK1JAK3PIK3C3
SCHEMBL18409104 0.80 JAK2 (0.43) TYK2JAK2JAK1JAK3PIK3C3
SCHEMBL18398518 0.79 TYK2 (0.43) TYK2JAK2JAK1JAK3GSK3B
SCHEMBL18398598 0.79 TYK2 (0.47) TYK2JAK2JAK1JAK3GSK3B
SCHEMBL18398420 0.79 TYK2 (0.42) TYK2JAK2JAK1JAK3GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback